BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37950594)

  • 1. Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Zhang Y; Wang C; Zhao Z; Cheng L; Xu S; Xie P; Xie L; Zhang S
    Int J Gynaecol Obstet; 2024 Jun; 165(3):959-968. PubMed ID: 37950594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
    Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
    Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
    Li Z; Duan H; Guo J; Yang Y; Wang W; Hao M; Li W; Li P; Bin X; Lang J; Liu P; Chen C
    Ann Transl Med; 2022 Jan; 10(2):122. PubMed ID: 35282078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Duan H; Li H; Kang S; Zhao H; Chen B; Wang L; Li P; Wang Y; Wang W; Lang J; Liu P; Chen C
    Acta Obstet Gynecol Scand; 2023 Aug; 102(8):1045-1052. PubMed ID: 37338046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenectomy increases the prognostic value of the revised 2009 FIGO staging system for endometrial cancer: a multi-center study.
    Kim HS; Kim HY; Park CY; Lee JM; Lee JK; Cho CH; Kim SM; Kim JW
    Eur J Surg Oncol; 2012 Mar; 38(3):230-7. PubMed ID: 22244682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametrial involvement and decreased survival of women with FIGO stage IIIC1 cervical cancer.
    Chang H; Wang M; Liu Y; Wu Y
    J Gynecol Oncol; 2023 Jul; 34(4):e46. PubMed ID: 36929577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the 2018 FIGO cervical cancer staging system.
    Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
    Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China.
    Liu X; Wang J; Hu K; Zhang F; Meng Q; Wang W; Wang D; Zhou Z; Ren K
    Cancer Manag Res; 2020; 12():1405-1410. PubMed ID: 32161492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
    Shin W; Ham TY; Park YR; Lim MC; Won YJ
    Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
    Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
    McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
    Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
    de Gregorio A; Widschwendter P; Ebner F; Friedl TWP; Huober J; Janni W; de Gregorio N
    Oncology; 2020; 98(2):91-97. PubMed ID: 31593942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
    Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
    Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.
    Qin F; Pang H; Yu T; Luo Y; Dong Y
    Technol Cancer Res Treat; 2022; 21():15330338221086403. PubMed ID: 35341413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.